Page last updated: 2024-08-24

2-methoxyestradiol and Genetic Predisposition

2-methoxyestradiol has been researched along with Genetic Predisposition in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonacasa, B; Bosch, V; Corno, A; Delgado, JL; Fenoy, FJ; Hernández, I; Hernández, M; López, B; Mendiola, J; Pertegal, M	1
Figueroa-Diesel, H; Galaz, J; Illanes, SE; Larraín, R; Michea, L; Nien, JK; Pérez-Sepúlveda, A; Serra, R; Torres, MJ; Valenzuela, FJ	1
Figg, WD; Lakhani, NJ; Sparreboom, A; Venitz, J	1

Reviews

1 review(s) available for 2-methoxyestradiol and Genetic Predisposition

Article	Year
Pharmacogenetics of estrogen metabolism and transport in relation to cancer. Current drug metabolism, 2003, Volume: 4, Issue:6 Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Diethylstilbestrol; Estradiol; Estrogens; Female; Genetic Predisposition to Disease; Humans; Male; Neoplasms	2003

Other Studies

2 other study(ies) available for 2-methoxyestradiol and Genetic Predisposition

Article	Year
Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia. Fertility and sterility, 2016, Volume: 105, Issue:1 Topics: 2-Methoxyestradiol; Adult; Biomarkers; Blood Pressure; Case-Control Studies; Catechol O-Methyltransferase; Chi-Square Distribution; Estradiol; Female; Fetal Blood; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Homocysteine; Hospitals, University; Humans; Logistic Models; Methylenetetrahydrofolate Reductase (NADPH2); Multivariate Analysis; Odds Ratio; Phenotype; Placenta; Polymorphism, Single Nucleotide; Pre-Eclampsia; Pregnancy; Prospective Studies; Risk Assessment; Risk Factors; Spain	2016
Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia. Prenatal diagnosis, 2012, Volume: 32, Issue:11 Topics: 2-Methoxyestradiol; Adult; Case-Control Studies; Catechol O-Methyltransferase; Estradiol; Female; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Tubulin Modulators	2012

Article

Year

Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia.

Fertility and sterility, 2016, Volume: 105, Issue:1

Topics: 2-Methoxyestradiol; Adult; Biomarkers; Blood Pressure; Case-Control Studies; Catechol O-Methyltransferase; Chi-Square Distribution; Estradiol; Female; Fetal Blood; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Homocysteine; Hospitals, University; Humans; Logistic Models; Methylenetetrahydrofolate Reductase (NADPH2); Multivariate Analysis; Odds Ratio; Phenotype; Placenta; Polymorphism, Single Nucleotide; Pre-Eclampsia; Pregnancy; Prospective Studies; Risk Assessment; Risk Factors; Spain

2016

Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia.

Prenatal diagnosis, 2012, Volume: 32, Issue:11

Topics: 2-Methoxyestradiol; Adult; Case-Control Studies; Catechol O-Methyltransferase; Estradiol; Female; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Tubulin Modulators

2012